Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre

被引:26
作者
Rogers, Kerry A. [1 ]
Huang, Ying [1 ]
Dotson, Emily [2 ]
Lundberg, Jordan [2 ]
Andritsos, Leslie A. [1 ]
Awan, Farrukh T. [1 ]
Woyach, Jennifer A. [1 ]
Byrd, John C. [1 ]
机构
[1] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Pharm, Columbus, OH 43210 USA
关键词
Richter syndrome; chronic lymphocytic leukaemia; PD-1 (PDCD1) inhibitors; immune checkpoint inhibitors; CHEMOIMMUNOTHERAPY;
D O I
10.1111/bjh.15508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:363 / 366
页数:4
相关论文
共 9 条
[1]  
[Anonymous], 2017, BLOOD S1
[2]   Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL [J].
Ding, Wei ;
LaPlant, Betsy R. ;
Call, Timothy G. ;
Parikh, Sameer A. ;
Leis, Jose F. ;
He, Rong ;
Shanafelt, Tait D. ;
Sinha, Sutapa ;
Le-Rademacher, Jennifer ;
Feldman, Andrew L. ;
Habermann, Thomas M. ;
Witzig, Thomas E. ;
Wiseman, Gregory A. ;
Lin, Yi ;
Asmus, Erik ;
Nowakowski, Grzegorz S. ;
Conte, Michael J. ;
Bowen, Deborah A. ;
Aitken, Casey N. ;
Van Dyke, Daniel L. ;
Greipp, Patricia T. ;
Liu, Xin ;
Wu, Xiaosheng ;
Zhang, Henan ;
Secreto, Charla R. ;
Tian, Shulan ;
Braggio, Esteban ;
Wellik, Linda E. ;
Micallef, Ivana ;
Viswanatha, David S. ;
Yan, Huihuang ;
Chanan-Khan, Asher A. ;
Kay, Neil E. ;
Dong, Haidong ;
Ansell, Stephen M. .
BLOOD, 2017, 129 (26) :3419-3427
[3]   Pharmacokinetics of Idelvion (rIX-FP) in a Patient with Renal Failure [J].
Kotowski, Adam S. ;
Jain, Shilpa ;
Ambrusko, Steven John ;
Belling, Linda ;
Kovach, Karen .
BLOOD, 2016, 128 (22)
[4]   PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma [J].
Nayak, Lakshmi ;
Iwamoto, Fabio M. ;
LaCasce, Ann ;
Mukundan, Srinivasan ;
Roemer, Margaretha G. M. ;
Chapuy, Bjoern ;
Armand, Philippe ;
Rodig, Scott J. ;
Shipp, Margaret A. .
BLOOD, 2017, 129 (23) :3071-3073
[5]   How we treat Richter syndrome [J].
Parikh, Sameer A. ;
Kay, Neil E. ;
Shanafelt, Tait D. .
BLOOD, 2014, 123 (11) :1647-1657
[6]  
Richter MN, 1928, AM J PATHOL, V4, P285
[7]   A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor [J].
Rogers, Kerry A. ;
Huang, Ying ;
Ruppert, Amy S. ;
Salem, Galena ;
Stephens, Deborah M. ;
Heerema, Nyla A. ;
Andritsos, Leslie A. ;
Awan, Farrukh T. ;
Byrd, John C. ;
Flynn, Joseph M. ;
Maddocks, Kami J. ;
Jones, Jeffrey A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (02) :259-266
[8]   The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation [J].
Rossi, Davide ;
Spina, Valeria ;
Deambrogi, Clara ;
Rasi, Silvia ;
Laurenti, Luca ;
Stamatopoulos, Kostas ;
Arcaini, Luca ;
Lucioni, Marco ;
Rocque, Gabrielle B. ;
Xu-Monette, Zijun Y. ;
Visco, Carlo ;
Chang, Julie ;
Chigrinova, Ekaterina ;
Forconi, Francesco ;
Marasca, Roberto ;
Besson, Caroline ;
Papadaki, Theodora ;
Paulli, Marco ;
Larocca, Luigi M. ;
Pileri, Stefano A. ;
Gattei, Valter ;
Bertoni, Francesco ;
Foa, Robin ;
Young, Ken H. ;
Gaidano, Gianluca .
BLOOD, 2011, 117 (12) :3391-3401
[9]   Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation [J].
Tsimberidou, Apostolia-Maria ;
O'Brien, Susan ;
Khouri, Issa ;
Giles, Francis J. ;
Kantarjian, Hagop M. ;
Champlin, Richard ;
Wen, Sijin ;
Do, Kim-Anh ;
Smith, Susan C. ;
Lerner, Susan ;
Freireich, Emil J. ;
Keating, Michael J. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2343-2351